RecruitingNot ApplicableNCT07342634

Effect of Blood Flow Restriction on Recovery After Maximal Resistance Exercise

Effect of Blood Flow Restriction on Recovery After Maximal Resistance Exercise: a Controlled Clinical Trial


Sponsor

Paulista University

Enrollment

80 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Resistance training has been widely performed due to its health benefits. However, performing this training at high intensity causes significant muscle stress, leading to fatigue and compromising performance. It is essential to implement effective recovery strategies to optimize physiological adaptations. Among the accessible techniques, blood flow restriction (BFR) has shown promise for its potential to accelerate muscle recovery.


Eligibility

Min Age: 18 YearsMax Age: 35 Years

Inclusion Criteria5

  • Individuals exhibiting one or more of the following characteristics will not be included:
  • (1) diabetes and hypertension;
  • (2) inflammatory rheumatological, psychiatric, cardiovascular and/or respiratory disease;
  • (3) pre-existing injury restricting their ability to perform vigorous physical activities;
  • (4) having one or more predisposing risk factors for thromboembolism.

Exclusion Criteria5

  • Participants will be excluded from the study if they:
  • (1) have a health problem that does not allow them to continue;
  • (2) wish to leave the study;
  • (3) use medications, electrotherapy, or other therapeutic methods during the study period that could interfere with any results;
  • (4) not sign the consent form.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBFR-80%

Will perform the intervention with BFR using 80% of the total occlusion pressure (TOP) continuously for 20 minutes.

DEVICEBFR-60%

Will perform the intervention with BFR using 60% of the total occlusion pressure (TOP) continuously for 20 minutes.

OTHERBFR-10mmHg

Will perform the intervention with BFR using 10 mmHg of occlusion pressure continuously for 20 minutes.


Locations(1)

Franciele Marques Vanderlei

Presidente Prudente, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07342634


Related Trials